Ultimate Bellaire
Oct 2 2012

Hagop Kantarjian named to Actinium Pharmaceuticals Clinical Advisory Board

by Journatic News Service | October 2, 2012 12:55 pm

Dr. Hagop Kantarjian has been named to the Actinium Pharmaceuticals
Clinical Advisory Board in New York.

Kantarjian previously served as chairman of the Leukemia Department
and professor of medicine at the University of Texas MD Anderson
Cancer Center.

Kantarjian also served as clinical and scientific advisor of ChemGenex
Therapeutics Inc. and as a member of the Astex Therapeutics Limited’s
Scientific Advisory Board.

Kantarjian obtained his medical degree from American University of
Beirut. He is board certified in internal medicine, medical oncology
and hematology.

Actinium Pharmaceuticals Inc. is a biopharmaceutical company
specialized in the development of cancer drugs.